All In MedTech

Device Trial Radar · NCT07357480

Comparison of Target-Controlled and Manual Total Intravenous Anesthesia in Supratentorial Surgery

Comparison of Target-Controlled Infusion Using the Eleveld Model and Manual Total Intravenous Anesthesia on Intraoperative Anesthetic Consumption and Postoperative Pain and Delirium in Supratentorial Surgery

Last checked: Nov 19, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

63

Actual

Start

Jan 14, 2026

Primary completion

Jun 7, 2026

Study completion Jul 16, 2026

Sponsor

Lead sponsor
Istanbul University - CerrahpasaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 22, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to investigate the effect of target-controlled infusion using the Eleveld pharmacokinetic model compared with manually controlled total intravenous anesthesia on the incidence of postoperative delirium in patients undergoing supratentorial surgery. Propofol and remifentanil are administered using either target-controlled or manual infusion techniques according to the study protocol. Secondary objectives include comparisons of intraoperative anesthetic consumption, hemodynamic responses, recovery profiles, postoperative pain, and postoperative nausea and vomiting between the two anesthesia strategies. The study seeks to evaluate whether target-controlled infusion provides improved anesthetic management and postoperative outcomes compared with manual total intravenous anesthesia.

Conditions

  • Postoperative Delirium (POD)
  • Postoperative Pain
  • PONV
  • Burst Suppression
  • Recovery Period, Anesthesia

Interventions

  • Target Controlled InfusionDevice

    Total Intravenous Anesthesia (TIVA) will be administered using an infusion pump (e.g., BeneFusion nSP) equipped with the Eleveld pharmacokinetic model. Propofol will be initiated at a target concentration of 3-3.5 µg/ml, and Remifentanil at 2-3 ng/ml (effect-site targeting). The "opioid present" option will be selected for the propofol model. Doses will be titrated to maintain a Bispectral Index (BIS) value between 40-60 throughout the surgery.

  • Total Intravenous Anesthesia(TIVA)Device

    Total Intravenous Anesthesia (TIVA) will be administered via manual titration. Induction will be performed with 20 mg propofol boluses based on EEG changes on the BIS monitor, followed by a remifentanil infusion of 0.1 µg/kg/min. Maintenance doses will be manually adjusted by the anesthesiologist to maintain a Bispectral Index (BIS) value between 40-60 and hemodynamic stability.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Postoperative DeliriumTime frame: Postoperative 72 hours

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine

    Istanbul, Bakırköy, Turkey (Türkiye)

  • Cerrahpaşa Tıp Fakültesi Murat Dilmener Hastanesi

    Istanbul, Istanbul, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.